Betta Pharmaceutical announced that the company's application for clinical trials of injectable BPI-585771 intended to treat advanced solid tumors has been accepted by the State Drug Administration. The acceptance number is CXHL2601308.

Zhitongcaijing · 2d ago
Betta Pharmaceutical announced that the company's application for clinical trials of injectable BPI-585771 intended to treat advanced solid tumors has been accepted by the State Drug Administration. The acceptance number is CXHL2601308.